Liver resection for metastatic colorectal cancer in the age of neoadjuvant chemotherapy and bevacizumab.
about
Herbal medicines for advanced colorectal cancerHerbal medicines for advanced colorectal cancerA Systematic Review and Network Meta-Analysis of Biologic Agents in the First Line Setting for Advanced Colorectal CancerDesigning liver resections and pushing the envelope with resections for hepatic colorectal metastasesFollow-up strategies for patients treated for non-metastatic colorectal cancer.Debulking treatment with CT-guided percutaneous radiofrequency ablation and hepatic artery infusion of floxuridine improves survival of patients with unresectable pulmonary and hepatic metastases of colorectal cancerIntraperitoneal ziv-aflibercept effectively manages refractory ascites in colorectal cancer patients.Oncological outcome of unresectable lung metastases without extrapulmonary metastases in colorectal cancer.A systematic review of treatment guidelines for metastatic colorectal cancerMetastatic rectal cancer to the breast.Phase II study of weekly irinotecan and capecitabine treatment in metastatic colorectal cancer patientsPercutaneous Cryoablation of Metastatic Lesions from Colorectal Cancer: Efficacy and Feasibility with Survival and Cost-Effectiveness Observations.Weichang'an and 5-fluorouracil suppresses colorectal cancer in a mouse modelEfficacy of chemotherapy plus bevacizumab as first-line therapy in patients with metastatic colorectal cancer: a meta-analysis and up-dateDisruption of thioredoxin metabolism enhances the toxicity of transforming growth factor β-activated kinase 1 (TAK1) inhibition in KRAS-mutated colon cancer cells.The preoperative SUVmax for (18)F-FDG uptake predicts survival in patients with colorectal cancer.Mechanisms regulating colorectal cancer cell metastasis into liver (Review).Comparison of KRAS/BRAF mutations between primary tumors and serum in colorectal cancer: Biological and clinical implications.A phase II, randomized study of aprepitant in the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapies in colorectal cancer patients.Predictive effects of bilirubin on response of colorectal cancer to irinotecan-based chemotherapy.Discovery and validation of the antimetastatic activity of citalopram in colorectal cancer.Serum Ferritin as a Prognostic Biomarker for Survival in Relapsed or Refractory Metastatic Colorectal Cancer.Methylation levels of LINE-1 in primary lesion and matched metastatic lesions of colorectal cancerCadherin-12 enhances proliferation in colorectal cancer cells and increases progression by promoting EMT.Local Control by Radiofrequency Thermal Ablation Increased Overall Survival in Patients With Refractory Liver Metastases of Colorectal Cancer.Tissue microarray analysis of 560 patients with colorectal adenocarcinoma: high expression of HuR predicts poor survival.Nesfatin-1/Nucleobindin-2 enhances cell migration, invasion, and epithelial-mesenchymal transition via LKB1/AMPK/TORC1/ZEB1 pathways in colon cancer.TPX2 is a novel prognostic marker for the growth and metastasis of colon cancerSequencing of treatment in metastatic colorectal cancer: where to fit the targetAnti-EGFR and anti-VEGF agents: important targeted therapies of colorectal liver metastases.Treatment recommendations for metastatic colorectal cancer.The management of rectal cancer with synchronous liver metastases: a modern surgical dilemma.Ziv-aflibercept (Zaltrap) for the treatment of metastatic colorectal cancer.MOLECULAR PATHWAYS: TARGETING THE MICROENVIRONMENT OF LIVER METASTASES.Early detection of poor outcome in patients with metastatic colorectal cancer: tumor kinetics evaluated by circulating tumor cells.Resection of colorectal liver metastases following neoadjuvant chemotherapy.Kinesin 18A expression: clinical relevance to colorectal cancer progression.SNORA21 - An Oncogenic Small Nucleolar RNA, with a Prognostic Biomarker Potential in Human Colorectal Cancer.Intraoperative margin re-resection for colorectal cancer liver metastases.Practical questions in liver metastases of colorectal cancer: general principles of treatment.
P2860
Q24197971-741199E1-BCFE-4A76-9468-77A0B1F54A37Q24200914-6E2015E1-645A-4093-B8DA-10CFD2D89A86Q26782245-BBEC59F0-4967-44FC-88F7-E46AD158C798Q26864128-28943C64-8B6C-4F85-A2C4-89AD566ACEB9Q30240736-DB5DE877-4E57-4362-9CCB-022F37E4F421Q33764110-1A7F9084-932C-4229-94B8-3B564A1DCDB9Q33829621-5D0190F2-261C-41A9-B7FC-B90CAA00B390Q33978181-97981413-5F81-47CE-9949-25E33F318602Q33995028-B6517E95-D401-4C71-91B9-FCD5352D2D0BQ34364631-28A64219-574C-49C8-A19A-E5B71BACF130Q34991668-1575E908-765E-4B2F-B03E-A3E3FFB17397Q34993548-6411FD81-6494-40B3-B74D-13283FA4110BQ35012033-2D1187ED-2667-46D6-9361-2B7AB59E0F0BQ35173951-A3BC9B1D-77D5-48E4-8831-1BAECB92D0D2Q35818332-9A9A8EDC-C866-44AE-A012-20706424452EQ35874307-1F3065FF-C437-4280-BEEC-063FBDC2429EQ35995311-61CF1147-C225-4094-85BA-D4E5F606B0B2Q36475875-148BBEB3-B449-40A3-8DDE-D98781FAD71AQ36640676-09FFC2B4-7172-4568-B5EE-6B76B46D129DQ36815039-13D68A90-D189-4C6A-90EA-8BB76E45BC79Q36997568-A900A3C3-1715-492F-BFDE-4F5456431533Q37012061-B71C5461-1532-4B64-8FA0-5C1BEF473C0AQ37040644-4B68BD38-47FC-48CB-B9C5-4212D8EB2F47Q37188216-7BBB5A4C-A493-40BD-BC95-DD7297666819Q37206861-BDDEF1A9-3FDD-4C78-831B-F72259711DF8Q37325542-C474600D-18CF-4F1A-A3A7-E2C6A70A58C9Q37327751-25062912-8814-4CA2-8512-DF5FF513CB0FQ37426758-B12969CE-33C0-4054-85CF-88AB393AA293Q37602729-F14BB9D3-E7F2-4776-8F31-26CEA3281561Q37708019-3E9E1DEC-AED4-4F66-B85C-291C65E4F3E8Q37855303-BFD67C51-7D21-4B22-9E45-9A196FED0C98Q38046472-F7020BAB-93E7-4ABA-B263-E57DC52EDB62Q38164658-1F5C59FA-ACBB-411C-8E6A-48348C7FC399Q38671001-B538F0C2-EFC2-475E-AD33-D446070759ACQ39345874-A7406091-58F5-4FF8-9AB3-59633AD1DF8EQ39369342-ABFF3B99-5C78-492B-9067-E328E5B31FB3Q39611073-A8E5B925-9044-4E5E-B83C-2EC11CD34B0CQ41348590-6E09BD52-71B5-4975-BAD5-6037AF360151Q41955679-4B3BA938-0A61-4C9D-9DA4-AA3F2BB413E1Q42278220-F10E8779-C98C-4FAB-85D4-DEA9CA069A00
P2860
Liver resection for metastatic colorectal cancer in the age of neoadjuvant chemotherapy and bevacizumab.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Liver resection for metastatic ...... chemotherapy and bevacizumab.
@ast
Liver resection for metastatic ...... chemotherapy and bevacizumab.
@en
type
label
Liver resection for metastatic ...... chemotherapy and bevacizumab.
@ast
Liver resection for metastatic ...... chemotherapy and bevacizumab.
@en
prefLabel
Liver resection for metastatic ...... chemotherapy and bevacizumab.
@ast
Liver resection for metastatic ...... chemotherapy and bevacizumab.
@en
P2093
P921
P356
P1476
Liver resection for metastatic ...... chemotherapy and bevacizumab.
@en
P2093
Charles H Cha
Peter S Yoo
Reynold I Lopez-Soler
Walter E Longo
P304
P356
10.3816/CCC.2006.N.036
P407
P577
2006-09-01T00:00:00Z